APRINOIA Therapeutics Corporation
Supporting the treatment of neurodegenerative diseases and brain health through next-generation diagnostic imaging and research of targeted therapeutic agents
Face to Face with a variety of players
Through communication, the possibilities of business realization will expand.
※Due to the convenience of each company, the number of logos posted is less than the number of tenants.
(Number of tenants: 73 companies as of November 1, 2024)